2-(2,6-dioxopiperidin-3-yl)-4-((2-((6-methoxy-4-(((R)-1-(3-(trifluoromethyl)phenyl)ethyl)amino)quinazolin-7-yl)oxy)ethyl)amino)isoindoline-1,3-dione

ID: ALA5283419

Max Phase: Preclinical

Molecular Formula: C33H29F3N6O6

Molecular Weight: 662.63

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(N[C@H](C)c3cccc(C(F)(F)F)c3)ncnc2cc1OCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O

Standard InChI:  InChI=1S/C33H29F3N6O6/c1-17(18-5-3-6-19(13-18)33(34,35)36)40-29-21-14-25(47-2)26(15-23(21)38-16-39-29)48-12-11-37-22-8-4-7-20-28(22)32(46)42(31(20)45)24-9-10-27(43)41-30(24)44/h3-8,13-17,24,37H,9-12H2,1-2H3,(H,38,39,40)(H,41,43,44)/t17-,24?/m1/s1

Standard InChI Key:  SYLBANHMIMFDAU-BPNWFJGMSA-N

Molfile:  

 
     RDKit          2D

 48 53  0  0  0  0  0  0  0  0999 V2000
    2.1836   -0.6238    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7532   -1.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5398   -1.1393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8924   -1.8987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6791   -2.0615    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2686   -2.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5633   -2.0343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8580   -2.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8580   -3.2549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5633   -3.6619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2686   -3.2549    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1528   -2.0343    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4475   -2.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2577   -2.0343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9629   -2.4413    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6682   -2.0343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3734   -2.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0787   -2.0343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7839   -2.4413    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4621   -2.0343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4621   -1.2206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7839   -0.8137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0787   -1.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3734   -0.8137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6682   -1.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9629   -0.8137    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2577   -1.2206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7839    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4621    0.4068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1673    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4621    1.2205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1673    1.6274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1673    2.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4621    2.8481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7839    2.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7839    1.6274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0787    2.8481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3734    3.2549    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0787    3.6619    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3734    2.4412    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.9467   -0.4340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7605   -0.4340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1673    0.2712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7605    0.9764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9467    0.9764    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5398    0.2712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7261    0.2712    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1673    1.6817    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  2  7  1  0
  7  6  1  0
  7  8  2  0
  8  9  1  0
 10  9  2  0
  6 11  2  0
 11 10  1  0
  8 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 22 21  1  0
 18 23  1  0
 23 22  2  0
 24 23  1  0
 16 25  1  0
 25 24  2  0
 25 26  1  0
 26 27  1  0
 22 28  1  0
 28 29  1  0
 29 30  1  6
 29 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 31 36  1  0
 36 35  2  0
 35 37  1  0
 37 38  1  0
 37 39  1  0
 37 40  1  0
  3 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  1  0
 45 44  1  0
 41 46  1  0
 46 45  1  0
 46 47  2  0
 44 48  2  0
M  END

Alternative Forms

  1. Parent:

    ALA5283419

    ---

Associated Targets(Human)

SOS1 Tchem Cereblon/SOS1 (72 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 662.63Molecular Weight (Monoisotopic): 662.2101AlogP: 4.72#Rotatable Bonds: 10
Polar Surface Area: 151.85Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.59CX Basic pKa: 5.84CX LogP: 4.16CX LogD: 4.16
Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.16Np Likeness Score: -0.94

References

1. Bian Y, Alem D, Beato F, Hogenson TL, Yang X, Jiang K, Cai J, Ma WW, Fernandez-Zapico M, Tan AC, Lawrence NJ, Fleming JB, Yuan Y, Xie H..  (2022)  Development of SOS1 Inhibitor-Based Degraders to Target KRAS-Mutant Colorectal Cancer.,  65  (24.0): [PMID:36459180] [10.1021/acs.jmedchem.2c01300]

Source